These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26107887)

  • 1. Successful use of tigecycline for treatment of culture-negative pyogenic vertebral osteomyelitis.
    Seyman D; Berk H; Sepın-Ozen N; Kızılates F; Turk CC; Buyuktuna SA; Inan D
    Infect Dis (Lond); 2015; 47(11):783-8. PubMed ID: 26107887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of culture-negative pyogenic vertebral osteomyelitis: comparison with microbiologically confirmed pyogenic vertebral osteomyelitis.
    Kim J; Kim YS; Peck KR; Kim ES; Cho SY; Ha YE; Kang CI; Chung DR; Song JH
    Semin Arthritis Rheum; 2014 Oct; 44(2):246-52. PubMed ID: 24951277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial therapy and assessing therapeutic response in culture-negative pyogenic vertebral osteomyelitis: a retrospective comparative study with culture-positive pyogenic vertebral osteomyelitis.
    Yu D; Kim SW; Jeon I
    BMC Infect Dis; 2020 Dec; 20(1):939. PubMed ID: 33297994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of pyogenic postoperative and native vertebral osteomyelitis.
    Kim UJ; Bae JY; Kim SE; Kim CJ; Kang SJ; Jang HC; Jung SI; Song KH; Kim ES; Kim HB; Park WB; Kim NJ; Park KH
    Spine J; 2019 May; 19(5):880-887. PubMed ID: 30500465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tigecycline in the management of osteomyelitis: a case series from the bone and joint infection (BAJIO) database.
    Griffin AT; Harting JA; Christensen DM
    Diagn Microbiol Infect Dis; 2013 Nov; 77(3):273-7. PubMed ID: 24029432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis.
    Lauf L; Ozsvár Z; Mitha I; Regöly-Mérei J; Embil JM; Cooper A; Sabol MB; Castaing N; Dartois N; Yan J; Dukart G; Maroko R
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):469-80. PubMed ID: 24439136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of tigecycline used as monotherapy or in combination regimens for complicated infections with documented involvement of multiresistant bacteria.
    Heizmann WR; Löschmann PA; Eckmann C; von Eiff C; Bodmann KF; Petrik C
    Infection; 2015 Feb; 43(1):37-43. PubMed ID: 25367409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing trends in the epidemiology of pyogenic vertebral osteomyelitis: the impact of cases with no microbiologic diagnosis.
    Lora-Tamayo J; Euba G; Narváez JA; Murillo O; Verdaguer R; Sobrino B; Narváez J; Nolla JM; Ariza J
    Semin Arthritis Rheum; 2011 Oct; 41(2):247-55. PubMed ID: 21665246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of tigecycline in critically ill patients with serious nosocomial intra-abdominal infections.
    Maseda E; Denis SE; Riquelme A; Gilsanz F
    Rev Esp Quimioter; 2013 Mar; 26(1):56-63. PubMed ID: 23546465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical and surgical treatment of pyogenic spondylodiscitis.
    Pola E; Logroscino CA; Gentiempo M; Colangelo D; Mazzotta V; Di Meco E; Fantoni M
    Eur Rev Med Pharmacol Sci; 2012 Apr; 16 Suppl 2():35-49. PubMed ID: 22655482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tigecycline in the management of post-neurosurgical spondylodiscitis: a review of eight cases.
    Sipahi OR; Kahraman H; Mermer S; Pullukcu H; Tasbakan M; Arda B; Yamazhan T; Yurtseven T; Aydemir S; Ulusoy S
    Int J Infect Dis; 2014 Jun; 23():16-9. PubMed ID: 24657273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.
    Garrison MW; Neumiller JJ; Setter SM
    Clin Ther; 2005 Jan; 27(1):12-22. PubMed ID: 15763603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous pyogenic vertebral osteomyelitis and endocarditis: incidence, risk factors, and outcome.
    Pigrau C; Almirante B; Flores X; Falco V; Rodríguez D; Gasser I; Villanueva C; Pahissa A
    Am J Med; 2005 Nov; 118(11):1287. PubMed ID: 16271915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy of tigecycline and teicoplanin in an experimental methicillin-resistant Staphylococcus aureus osteomyelitis model.
    Kandemir O; Oztuna V; Colak M; Akdag A; Camdeviren H
    J Chemother; 2008 Feb; 20(1):53-7. PubMed ID: 18343744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic applications of tigecycline in the management of complicated skin and skin structure infections.
    Grolman DC
    Int J Infect Dis; 2007 May; 11 Suppl 1():S7-15. PubMed ID: 17603950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: a descriptive and comparative study of 219 cases.
    Colmenero JD; Jiménez-Mejías ME; Sánchez-Lora FJ; Reguera JM; Palomino-Nicás J; Martos F; García de las Heras J; Pachón J
    Ann Rheum Dis; 1997 Dec; 56(12):709-15. PubMed ID: 9496149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE; Rybak MJ
    Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local treatment of chronic osteomyelitis with surgical debridement and tigecycline-impregnated calcium hydroxyapatite: an experimental study.
    Kaya M; Şimşek-Kaya G; Gürsan N; Kireççi E; Dayi E; Gündoğdu B
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Mar; 113(3):340-7. PubMed ID: 22676826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential role of newer gram-positive antibiotics in the setting of osteomyelitis of adults.
    Moenster RP; Linneman TW; Call WB; Kay CL; McEvoy TA; Sanders JL
    J Clin Pharm Ther; 2013 Apr; 38(2):89-96. PubMed ID: 23442007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.